Purchase Order 15DDL124P00000026
- Not listed
- The U.S. Drug Enforcement Administration (DEA) awarded a $80,800.00 firm fixed price purchase order to Cayman Chemical Co Inc., a leading supplier of biochemical products and research tools to federal agencies. The purchase order is for the delivery of 16 synthetic substances, which Cayman Chemical specializes in producing. Cayman Chemical has established long-term relationships with government agencies, including the DEA, Centers for Disease Control and Prevention (CDC), Department of the Army,...
- The U.S. Drug Enforcement Administration (DEA) awarded a $117,910.00 Firm Fixed Price purchase order to Cayman Chemical Co Inc., a for-profit manufacturer of biochemicals and research tools located in Ann Arbor, Michigan. The contract is for the procurement of 16 substances to support the DEA's drug enforcement activities, with a period of performance ending on April 29, 2025. Cayman Chemical has a history of securing federal contracts from agencies such as the Defense Health Agency, Centers for...
- This is a $24,069 firm-fixed-price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a manufacturer of biochemical products and research tools. The contract supports the DEA's drug enforcement and analysis efforts by providing reference materials, analytical standards, and specialized reagents. Cayman Chemical has an established track record of supplying the DEA and other federal agencies, such as the Centers for Disease Control and Prevention...
- The Department of Justice Drug Enforcement Administration awarded a $30,300 firm fixed price purchase order to Cayman Chemical Co Inc. to process an order for six controlled substances through January 2025. The award stems from a January 2024 special notice requesting synthetic substances for pharmacological testing to support the Drug and Chemical Evaluation Section's work in gathering information on drugs of concern and potentially schedule substances not currently controlled. Cayman...
- This is a $38,450.00 firm fixed price purchase order awarded by the Drug Enforcement Administration (DEA) to Cayman Chemical Co Inc., a for-profit manufacturer of biochemical products and research tools. The purchase order is for 8 substances and has a completion date of June 27, 2024. Cayman Chemical is a major supplier of reference materials, analytical standards, and specialized reagents to federal agencies for drug enforcement, public health, and biomedical research. The company has...
- The Department of Justice Drug Enforcement Administration awarded a $17,350 purchase order to Cayman Chemical Co Inc. of Sterling, Virginia to provide reference materials to support evidence analysis in a laboratory system. The firm fixed price contract runs from October 2023 through September 2024 to deliver products that will aid the DEA in analyzing evidence as part of its mission to enforce controlled substances laws and regulations. Cayman Chemical will serve as the prime contractor on this...
- The Department of Justice Drug Enforcement Administration awarded a $22,850 purchase order to Cayman Chemical Co Inc. to provide reference materials needed to fulfill laboratory system requests for evidence analysis in support of DOJ programs. The one-year contract running from June 30, 2023 to June 29, 2024 utilizes a firm fixed price arrangement for the reference materials, which will be delivered to and utilized at the prime contractor's facility in Sterling, Virginia. No set aside...
- This is a federal delivery order contract awarded by the Centers for Disease Control and Prevention (CDC) to Cayman Chemical Co Inc. for the provision of DLS Traceable Opioid Kits. The contract is a firm fixed-price award with a ceiling value of $499,800.00 and a period of performance through September 28, 2023. Cayman Chemical Co Inc. is a leading supplier of biochemical products and research tools, with a focus on supporting government agencies in areas such as drug enforcement, public...
- This is a firm-fixed price BPA call order awarded by the Defense Health Agency (DHA) to Cayman Chemical Co Inc., a leading manufacturer of biochemical products and research tools. The contract, valued at $11,540.48, is for the delivery of drug standards to be used for drug screening and evaluation testing of service member specimens. Cayman Chemical has an established track record of providing reference materials, analytical standards, and specialized reagents to support federal agencies' drug...
- Cayman Chemical Co Inc. has been awarded a firm fixed price blanket purchase agreement (BPA) call contract valued at ten thousand seven hundred eighty-eight dollars and twenty cents ($10,788.20) by the Defense Health Agency. Under this contract, Cayman Chemical will provide standards to the agency for use in screening and confirmation of suspected drug use in service member and/or post-mortem urine, blood, and tissue samples. Performance will occur in Ann Arbor, Michigan and the contract is...
The U.S. Drug Enforcement Administration (DEA) awarded a firm-fixed-price purchase order contract to Cayman Chemical Co Inc., a leading supplier of biochemical products and research tools, for the delivery of DEA-19 RMP CAYMAN 07192024 reference materials. The $31,179 contract, with a completion date of September 30, 2024, does not utilize a set-aside designation. Cayman Chemical, a for-profit manufacturer, has a strong track record of providing specialized chemicals, assay kits, and other critical supplies to federal agencies, including the DEA, Centers for Disease Control and Prevention, Department of the Army, and Environmental Protection Agency, to support their forensic analysis, substance abuse prevention, and research initiatives. This purchase order is part of Cayman Chemical's broader portfolio of federal contract vehicles and grant awards, which demonstrate the company's extensive capabilities in the government market.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $31.2k | 8/5/24 |